Merit Medical Systems (NASDAQ:MMSI) Upgraded at BidaskClub

BidaskClub upgraded shares of Merit Medical Systems (NASDAQ:MMSI) from a sell rating to a hold rating in a research report released on Wednesday morning, BidAskClub reports.

A number of other equities research analysts have also recently issued reports on the company. Zacks Investment Research cut Merit Medical Systems from a buy rating to a hold rating in a research note on Tuesday, February 26th. Needham & Company LLC restated a buy rating on shares of Merit Medical Systems in a research note on Thursday, April 25th. Finally, ValuEngine cut Merit Medical Systems from a buy rating to a hold rating in a research note on Thursday, April 25th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have assigned a buy rating to the stock. Merit Medical Systems has a consensus rating of Buy and a consensus target price of $68.89.

Shares of Merit Medical Systems stock opened at $56.23 on Wednesday. Merit Medical Systems has a 12-month low of $48.51 and a 12-month high of $66.34. The company has a market cap of $3.09 billion, a PE ratio of 33.27, a P/E/G ratio of 2.40 and a beta of 1.06. The company has a current ratio of 2.36, a quick ratio of 1.25 and a debt-to-equity ratio of 0.39.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Tuesday, April 23rd. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.01. Merit Medical Systems had a return on equity of 10.99% and a net margin of 4.68%. The company had revenue of $238.35 million for the quarter, compared to analysts’ expectations of $236.53 million. During the same quarter in the prior year, the business posted $0.31 EPS. The business’s revenue was up 17.4% compared to the same quarter last year. As a group, equities analysts expect that Merit Medical Systems will post 2.02 earnings per share for the current fiscal year.

In other Merit Medical Systems news, Director Kent W. Stanger sold 1,216 shares of the stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $60.54, for a total transaction of $73,616.64. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Raul Jr. Parra sold 2,000 shares of the stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $57.11, for a total value of $114,220.00. Following the transaction, the chief financial officer now owns 2,000 shares in the company, valued at approximately $114,220. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,216 shares of company stock worth $489,537. 4.75% of the stock is owned by company insiders.

A number of hedge funds have recently bought and sold shares of the business. Marshall Wace North America L.P. boosted its stake in Merit Medical Systems by 4,296.3% in the first quarter. Marshall Wace North America L.P. now owns 60,977 shares of the medical instruments supplier’s stock valued at $3,770,000 after buying an additional 59,590 shares in the last quarter. FMR LLC boosted its stake in shares of Merit Medical Systems by 6.1% during the first quarter. FMR LLC now owns 1,735,494 shares of the medical instruments supplier’s stock valued at $107,306,000 after purchasing an additional 99,015 shares in the last quarter. Perceptive Advisors LLC boosted its stake in shares of Merit Medical Systems by 10.9% during the first quarter. Perceptive Advisors LLC now owns 1,053,098 shares of the medical instruments supplier’s stock valued at $65,113,000 after purchasing an additional 103,900 shares in the last quarter. M&T Bank Corp acquired a new stake in shares of Merit Medical Systems during the first quarter valued at about $252,000. Finally, Macquarie Group Ltd. boosted its stake in shares of Merit Medical Systems by 2.2% during the first quarter. Macquarie Group Ltd. now owns 1,140,000 shares of the medical instruments supplier’s stock valued at $70,487,000 after purchasing an additional 24,799 shares in the last quarter. Hedge funds and other institutional investors own 97.70% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.

Featured Article: Understanding Market Liquidity

Analyst Recommendations for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.